Company intelligence / Profile preview

AddBio

Ownership: Private
Development stage: Clinical

Overview

AddBio Inc. manufactures molecular research reagents and rapid diagnostic test kits, serving the biotechnology and healthcare sectors in Korea since 2013. The company emphasizes innovation in advanced diagnostic technology to improve human health and happiness. No clinical trial results are reported as the company focuses on diagnostics rather than therapeutics.

Modalities: Device (rapid diagnostic tests)Reagents for molecular research
Industry: Molecular Diagnostics

Drug pipeline

1 asset

Zolidd

Clinical

Indications: Dental implant instability

Beyond the preview

Go deeper on AddBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AddBio.

Explore the full profile